![James Kinley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 137 009 $ al 31/07/2026
James F.
Kinley is Chief Financial Officer & Director at Medicure, Inc. since 2026, Independent Director at Waverley Pharma, Inc. since 2024, Chief Financial Officer at Cytophage Technologies Ltd. since 2026, Chief Financial Officer & Secretary at Grey Matters Health, Inc. since 2022, and Chief Financial Officer at Algernon Neuroscience, Inc. Former roles include Principal at Ernst & Young LLP, Chief Financial Officer at Medicure, Inc. from 2011 to 2021, Manager at Manitoba Telecom Services, Inc., and Chief Financial Officer at Luminor Medical Technologies, Inc. from 2011 to 2016.
Education includes undergraduate studies at Asper School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GREY MATTERS HEALTH INC 7,04 % | 17/08/2026 | 381.492 ( 7,04 % ) | 94 610 $ | 31/07/2026 |
MEDICURE INC. 0,45 % | 02/04/2026 | 47.100 ( 0,45 % ) | 41 778 $ | 31/07/2026 |
| 05/05/2025 | 56.500 ( 0,1 % ) | 622 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GREY MATTERS HEALTH INC. | Director Financiero/CFO | 01/12/2021 |
| MEDICURE INC. | Director Financiero/CFO | 24/07/2026 |
| WAVERLEY PHARMA INC. | Director/Miembro de la Junta | 20/06/2024 |
| CYTOPHAGE TECHNOLOGIES LTD. | Director Financiero/CFO | 20/01/2026 |
Algernon Neuroscience, Inc. | Director Financiero/CFO | - |
| Empresas | Cargo | Fin |
|---|---|---|
| MEDICURE INC. | Director Financiero/CFO | 15/05/2021 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Director Financiero/CFO | 18/01/2016 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
| BELL MTS | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Medicure, Inc.
 Medicure, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research, development and commercialization & marketing of human therapeutics products | Health Technology |
Manitoba Telecom Services, Inc.
 Manitoba Telecom Services, Inc. Wireless TelecommunicationsCommunications Provides telecommunications services | Communications |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Asper School of Business
 Asper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algernon Pharmaceuticals, Inc.
 Algernon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage, drug development and repurposing company | Health Technology |
Waverley Pharma, Inc.
 Waverley Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Algernon Neuroscience, Inc. | |
Cytophage Technologies Ltd.
 Cytophage Technologies Ltd. Financial ConglomeratesFinance Produces bacteriophages for bacterial infections and diseases | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
